Researchers establish fetal brain organoids as a versatile platform for brain cancer modeling.
Adaptimmune gets FDA accelerated approval for T cell receptor cell therapy in rare soft tissue cancer
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS